CVE CVE
Company Profile ↓Company Overview
CVE (CVE) is a publicly traded company listed on with a market capitalization of $52.37B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 12.9.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $52.75B (-8.6% YoY); net profit $3.93B.
- Trailing 12 Months Year-on-year growth — revenue -8.6%, earnings +25.1%.
- 5-Year Trend Long-term compounding — revenue CAGR -9.8%, profit CAGR -15.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -9.75% |
| 1 Year: | -8.62% |
Compounded Profit Growth
| 5 Years: | -15.22% |
| 1 Year: | 25.08% |
Stock Price Performance
| 1 Year: | +88.19% |
| 6 Months: | +40.65% |
| 3 Months: | -8.42% |
| 1 Month: | +10.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)48.00 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -9.8% CAGR over 5 years.
- Earnings shrank at -15.2% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 12.94B | 13.20B | 13.94B | 13.34B | 19.09B |
| Cost of Revenue | - | 10.35B | 9.87B | 11.15B | 9.09B | 13.20B |
| Gross Profit | - | 2.59B | 3.33B | 2.79B | 4.25B | 5.89B |
| Operating Expenses | - | 1.90B | 1.81B | 1.65B | 1.89B | 1.61B |
| Operating Income | - | 690.00M | 1.51B | 1.14B | 2.36B | 4.28B |
| EBITDA | - | 2.35B | 2.78B | 2.59B | 3.76B | 5.63B |
| Interest Expense | - | 154.00M | 158.00M | 186.00M | 208.00M | 199.00M |
| Pretax Income | - | 1.02B | 1.30B | 1.03B | 2.08B | 3.94B |
| Tax Provision | - | 165.00M | 11.00M | 100.00M | 514.00M | 1.07B |
| Net Income | - | 851.00M | 1.29B | 934.00M | 1.57B | 2.87B |
| Diluted EPS | - | 0.45 | 0.72 | 0.50 | 0.83 | 1.53 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 71.77B | 55.47B | 57.73B | 52.75B |
| Cost of Revenue | - | 54.63B | 42.77B | 44.96B | 40.94B |
| Gross Profit | - | 17.13B | 12.70B | 12.77B | 11.82B |
| Operating Expenses | - | 6.78B | 7.08B | 7.70B | 7.19B |
| Operating Income | - | 10.35B | 5.62B | 5.06B | 4.63B |
| EBITDA | - | 14.22B | 10.41B | 9.59B | 10.33B |
| Interest Expense | - | 812.00M | 723.00M | 649.00M | 661.00M |
| Pretax Income | - | 8.73B | 5.04B | 4.07B | 4.48B |
| Tax Provision | - | 2.28B | 931.00M | 929.00M | 547.00M |
| Net Income | - | 6.45B | 4.11B | 3.14B | 3.93B |
| Diluted EPS | - | 3.20 | 2.12 | 1.67 | 2.15 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 55.87B | 53.91B | 56.54B | 63.42B |
| Current Assets | - | 12.43B | 9.71B | 10.43B | 9.89B |
| Cash & Equivalents | - | 4.52B | 2.23B | 3.09B | 2.74B |
| Inventory | - | 4.31B | 4.03B | 4.50B | 3.35B |
| Receivables | - | 2.96B | 2.72B | 2.38B | 3.05B |
| Total Liabilities | - | 28.28B | 25.20B | 26.77B | 31.79B |
| Current Liabilities | - | 8.02B | 6.21B | 7.36B | 6.31B |
| Long Term Debt | - | 8.69B | 7.11B | 7.34B | 11.03B |
| Total Debt | - | 11.64B | 9.95B | 10.63B | 14.21B |
| Total Equity | - | 27.58B | 28.70B | 29.75B | 31.62B |
| Shares Outstanding | - | 1.91B | 1.87B | 1.83B | 1.89B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 11.40B | 7.39B | 9.23B | 8.23B |
| Investing Cash Flow | - | -2.31B | -5.29B | -5.13B | -7.68B |
| Financing Cash Flow | - | -7.68B | -4.31B | -3.50B | -749.00M |
| Capital Expenditure | - | -3.76B | -4.30B | -5.01B | -4.91B |
| Free Cash Flow | - | 7.64B | 3.09B | 4.22B | 3.32B |
| Net Change in Cash | - | 1.41B | -2.22B | 604.00M | -198.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 23.9% | 22.9% | 22.1% | 22.4% |
| Operating Margin % | - | 14.4% | 10.1% | 8.8% | 8.8% |
| Net Margin % | - | 9.0% | 7.4% | 5.4% | 7.5% |
| ROE % | - | 23.4% | 14.3% | 10.6% | 12.4% |
| ROCE % | - | 21.6% | 11.8% | 10.3% | 8.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CVE
Cenovus Energy Inc (CVE) Stock Down 3.5% but Still Overvalued -- GF Score: 60/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNWWg4M0FvVklVTjhIcnJ1bTF6Mk05a2xWOE80TVc1QjF0djJacWo0RXlvYjNuZ2NSbV85LWJyUDhDUEJRLWNsOEtUWElTeUpNb1BKTks0Y2FmcG40OGtqY0ZyZWlpZUoyRnNMTHRFTjBkQ1AyYjNjc191a1RmcVBiT25VVkZ2VFVTNTdndW…
Cenovus Energy (CVE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQVDRDR1N6dTRPOG1WNjZpX2MyQVpkbGRmOGtzZlZBZUxtZTlFWlJIeTdBYUpod0poUWhPMWdESE5BWjdEMzNlbkRzZGNqSURESjljZUtRUWlDRUN2bk9wMkFKQXY4VVhfSm80bUxXZUhmNUtwNFlwR2oxVDNoQUJfY0lyTlNjSjhYMDVYZ0…
TD Forecasts Strong Price Appreciation for Cenovus Energy (TSE:CVE) Stock - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQU11bnRTMGdDdGY5bkFGaUd3Z1cybHhtN2JkbWhCallsNUtBdkdZNk5BT052SWdQMC0wb3FwUVZ0VUFiUUhITkN1RzVBTTJYenJaX2ZIeE52bUNheVBJRDhDS2VyeXlCb3FiWURoMm9WNHIxTlZyNHk3aTNHSWJrdVUzRTBHVlhUZXpNRm…
Cenovus Energy (TSX:CVE) Stock Looks Cheap But Earnings May Cool - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBEYlZBQ3RyTVBSMW9fUmgyZkQ3UkZ4cVM4cGFrM2Ezc191ZFV0S0VhT0YwOV9CYmZBSGtZNkRkWlZJeUxhOTE3MHdhR3p2VTdRLXo1a3oxUFU?oc=5" target="_blank">Cenovus Energy (TSX:CVE) Stock Looks Cheap But E…
Banyan Gold Corp - Google
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9VUF8zVXV1OXAxRkNSODBiaTVBMElrXzZ0ejMwT2drcG0yVXYtU2ZQS0NCcUVKUjZyTnJSMVgwLW1BaFJ6aHFLczlQX2NZaDRHMmdobE02TQ?oc=5" target="_blank">Banyan Gold Corp</a> <font color="#6f6…
Cenovus Energy (TSX:CVE) Stock Looks Above Fair Value Despite Lower Earnings Multiple - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNVDczT0hzZnhsaVRrWXJqZkczYVVHR1NTWjhvMGhHaUFZTHdlTEFKbzJxRFk3YTRvR01GbkMyUFNpQ2Z5SWY3cHVEcFJVc1lKRWt0eVFZSjQtdTZnWWxpVFFUdHRPZF9QcWJUWkxPM1pZOGM5UXA0bXdCRi1nSWM0c0h2M24weE5hSkRoWl…
CVE — Frequently Asked Questions
What is the current share price of CVE?
As of 2026-08-05 17:25 PDT, CVE trades at $27.73 on NASDAQ/NYSE. Its 52-week range is $14.33 to $31.62.
What is the market capitalisation of CVE?
CVE has a market capitalisation of $52.37B on NASDAQ/NYSE.
What is the P/E ratio of CVE?
CVE trades at a trailing price-to-earnings (P/E) ratio of 12.90. Its price-to-book (P/B) ratio is 1.66.
What is the return on equity (ROE) of CVE?
CVE has a return on equity (ROE) of 12.43%. Its return on capital employed (ROCE) is 8.10%.
Is CVE a good stock to buy?
This page provides a data-driven analysis of CVE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.